Latest Video Most Popular Video

CNBC's John Harwood reports highlights from Thursday night's Democratic debate where both candidates Hillary Clinton and Bernie Sanders challenge each other over the issues.

Traders work on the floor of the New York Stock Exchange.

U.S. stock futures were higher this morning, again taking cues from oil prices, which were gaining ground this morning.

Is fashion world ready for Zoolander? Friday, 5 Feb 2016 | 3:25 AM ET
Is fashion world ready for Zoolander?

CNBC's Phil Han caught up with the stars of the new Zoolander 2 film and talk about the fashion world, their relationships and U.S. politics.

Brett Favre drops in on Cramer Thursday, 4 Feb 2016 | 6:58 PM ET
Brett Favre visits Cramer

Mad Money host Jim Cramer receives a visit from future Hall-of-Fame QB for the Green Bay Packers, Brett Favre.

Sponsoring the Super Bowl Thursday, 4 Feb 2016 | 6:47 PM ET
Sponsoring the Super Bowl

CNBC's Jane Wells takes a look at Super Bowl 50 sponsors in the Bay area.

Cramer and Gronk talking smack Thursday, 4 Feb 2016 | 6:15 PM ET

Mad Money host Jim Cramer sits down with Ron Gronkowski of the New England Patriots just days for the big Super Bowl 50.

Shkreli's attorney: He's been unfairly vilified Thursday, 4 Feb 2016 | 6:08 PM ET
BRAFMAN FULL INTERVIEW

Former Turing Pharmaceuticals CEO Martin Shkreli was scheduled to testify to Congress today, but exercised his 5th Amendment right to not incriminate himself. Shkreli's lawyer Benjamin Brafman, explains his client's position.

Cramer explains the sudden flock to commodities Thursday, 4 Feb 2016 | 6:00 PM ET
Cramer explains the sudden flock to commodities

Mad Money host Jim Cramer explains the complicated relationship between the strength of the dollar and commodity stocks, and what it means to your portfolio.

5 divine dividend plays for you Thursday, 4 Feb 2016 | 5:15 PM ET
5 divine dividend plays for you

CNBC's Dom Chu reviews the criteria for divine dividend stocks.

Dwight Clark explains 'The Catch' Thursday, 4 Feb 2016 | 4:10 PM ET
Dwight Clark explains 'The Catch'

Dwight Clark, former wide receiver for the San Francisco 49ers, explains what happened when he caught a pass from Joe Montana which sent the team to its first Super Bowl in 1982. It's been simply called, "The Catch."

Jim Cramer on Brafman's attempt: My breath is taken away

Martin Shkreli's Attorney Benjamin Brafman attempted to address Congress in a hearing on drug price hikes, in which he was told to be seated. CNBC's Jim Cramer weighs in.

Cramer Remix: How to conquer rotations Thursday, 4 Feb 2016 | 7:00 PM ET
Cramer Remix: How to conquer rotations

“Mad Money” host Jim Cramer’s giving investors his insight on how to play rotations.

4 Divine dividend plays Thursday, 4 Feb 2016 | 5:00 PM ET
A dealer handles gaming chips at a baccarat table inside the Venetian Macau resort and casino, operated by Sands China Ltd., a unit of Las Vegas Sands Corp., in Macau, China.

The "Fast Money" traders give four ways to play stocks with great dividends.

Rep. Gowdy to Shkreli's attorney: You will be seated Thursday, 4 Feb 2016 | 10:06 AM ET
Rep. Gowdy to Shkreli's attorney: You wil be seated

Former Turing Pharmaceuticals CEO Martin Shkreli pleads the Fifth Amendment before Congress, and Shkreli's Attorney Benjamin Brafman attempts to address Congress.

Martin Shkreli on the Hill Thursday, 4 Feb 2016 | 9:20 AM ET
Martin Shkreli on the Hill

House Oversight Chairman Jason Chaffetz swears in the panel at the House Oversight Committee hearing on drug price hikes, where former Turing Pharmaceuticals CEO Martin Shkreli is testifying.

Shkreli tweets after pleading Fifth Thursday, 4 Feb 2016 | 10:20 AM ET
Shkreli tweets after pleading Fifth

Former Turing Pharmaceuticals CEO Martin Shkreli has tweeted after being excused from a drug price hearing on Capitol Hill. He says "it is hard to accept that these imbeciles represent the people in our government."

Martin Shkreli takes on Congress Thursday, 4 Feb 2016 | 12:12 PM ET
Martin Shkreli, former CEO of Turing Pharmaceuticals, prepares to testify before a House Oversight and Government Reform hearing on Capitol Hill, Feb. 4, 2016.

Martin Shkreli, the former drug company CEO who's come under fire for massive drug price increases, refused to testify Thursday before a congressional committee investigating drug price hikes.

Silent Shkreli smirks in courtroom Thursday, 4 Feb 2016 | 11:01 AM ET
Silent Shkreli smirks in courtroom

While Martin Shkreli said little in court, his expressions and activity on Twitter spoke volumes. CNBC's Meg Tirrell reports, Henry Blodget of Business Insider joins the discussion.

Faber Report: Shari Redstone battling Viacom Thursday, 4 Feb 2016 | 10:34 AM ET
Faber Report: Shari Redstone battling Viacom

CNBC's David Faber reports Viacom CEO Philippe Dauman is likely to be named Viacom Chairman, according to sources.

Drug prices debate Thursday, 4 Feb 2016 | 10:12 AM ET
Drug prices debate

CNBC's Meg Tirrell reports from Capitol Hill, where former Turing Pharmaceuticals CEO Martin Shkreli's invoked the Fifth Amendment at a drug price hike hearing.

Attorney: No disrespect, just 'nervous energy' by Shkreli

Former Turing Pharmaceuticals CEO Martin Shkreli's Attorney Benjamin Brafman speaks to the press after Shkreli was excused from a House panel hearing.

Cummings to Shkreli: You could change the system Thursday, 4 Feb 2016 | 9:49 AM ET
Cummings to Shkreli: You could change the system, are you listening?

Rep. Elijah Cummings presses former Turing Pharmaceuticals CEO Martin Shkreli on Capitol Hill, as he testifies before the House Oversight Committee hearing on drug price hikes, invoking the Fifth Amendment.

Shkreli pleads the Fifth Thursday, 4 Feb 2016 | 9:41 AM ET
Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, is sworn in before a House Oversight and Government Reform hearing on "Developments in the Prescription Drug Market Oversight" on Capitol Hill in Washington February 4, 2016.

Former Turing Pharmaceuticals CEO Martin Shkreli testifies before the House Oversight Committee hearing on drug price hikes, invoking the Fifth Amendment.

Jim Cramer: Drug price hearing 'not for show' Thursday, 4 Feb 2016 | 9:06 AM ET
Jim Cramer: Drug price hearing 'not for show'

The "Squawk on the Street" crew discuss the House Oversight Committee hearing on drug price hikes, where former Turing Pharmaceuticals CEO Martin Shkreli, and Valeant Pharmaceuticals interim CEO Howard Schiller are testifying.

Google's AI chief takes control of search Thursday, 4 Feb 2016 | 9:00 AM ET
Google search engine on mobile phone.

Google's head of its AI unit will takeover search. Will this shape a new way to search the entire web?

Can markets predict recessions? Thursday, 4 Feb 2016 | 7:04 AM ET
Can markets predict recessions?

CNBC's Steve Liesman takes a look at which bear markets leads to recession and which don't.

Futures point to higher market open Thursday, 4 Feb 2016 | 5:55 AM ET
Futures point to higher market open

Market volatility continues to be in evidence on Wall Street, with a late-day Wednesday comeback turning a triple-digit Dow loss into a triple-digit gain.

Sumner Redstone resigns as CBS executive chairman Thursday, 4 Feb 2016 | 5:09 AM ET
Sumner Redstone resigns as CBS executive chairman

It's the end of an era as media mogul Sumner Redstone steps down at CBC and CEO Les Moonves takes the reigns, reports CNBC's Landon Dowdy.

Are the markets overly bearish? Monday, 1 Feb 2016 | 2:41 PM ET
Are the markets overly bearish?

Robert Tipp of Prudential Fixed Income talks about where to find fixed-income opportunities.

It's time to be a contrarian investor: Bradshaw Monday, 1 Feb 2016 | 2:02 AM ET
It's time to be a contrarian investor: Amundi's Bradshaw

Myles Bradshaw, head of global aggregate fixed income at Amundi, says the market is pricing too high a probability of a world recession.